Quantification of Antisense Oligonucleotides by Splint Ligation and Quantitative Polymerase Chain Reaction
Minwook Shin,Pranathi Meda Krishnamurthy,Gitali Devi,Jonathan K. Watts
DOI: https://doi.org/10.1089/nat.2021.0040
2022-02-01
Nucleic Acid Therapeutics
Abstract:Reliable detection and quantification of antisense oligonucleotides (ASOs) in experimental and clinical specimens are essential to understand the biological function of novel oligonucleotide-based therapeutics. In this study, we describe a method to detect and quantify ASOs in biological samples, whereby the ASO acts as a splint to direct the ligation of complementary probes and quantitative real-time PCR was used to monitor ligation products. Low levels of 2'-<i>O</i>-methoxyethyl (2'-<i>O</i>-MOE) gapmer ASO in serum, liver, kidney, lung, heart, muscle, and brain tissues can be detected over a 6-log linear range for detection using this method. This method allows quantification of various types of chemically modified ASOs, including phosphorothioate linkage, 2'-<i>O</i>-methyl, 2'-<i>O</i>-MOE, and locked nucleic acid, as well as siRNAs. This method does not require probe modifications, and can be performed using standard laboratory equipment; making it a fast, sensitive, and reliable technique that can be widely applied. This detection method may find potential applications in detection of therapeutic oligonucleotides in biological samples.
biochemistry & molecular biology,chemistry, medicinal,medicine, research & experimental